Pyronaridine‐artesunate (PY‐AS) vs mefloquine plus artesunate (MQ + AS)
First treatment, abnormal ALT increase (42 days) · adults and children with uncomplicated P falciparum malaria
Pyronaridine‐artesunate (PY‐AS) showed no clear difference in first treatment, abnormal ALT increase (42 days) compared with mefloquine plus artesunate (MQ + AS) (low certainty).
1 finding from 1 review
- Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria 2022 · Cochrane Headline outcomes onlyRR 7.48 [0.99, 56.45]1 study · 1271 participantsLow